{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:37:12Z","timestamp":1794854232623,"version":"4.9.1"},"reference-count":216,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1038\/s41577-024-00994-x","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T11:04:11Z","timestamp":1708340651000},"page":"503-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":228,"title":["The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-2642","authenticated-orcid":false,"given":"Tomokazu S.","family":"Sumida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardos T.","family":"Cheru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-535X","authenticated-orcid":false,"given":"David A.","family":"Hafler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"994_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nri.2017.75","volume":"17","author":"L Lu","year":"2017","unstructured":"Lu, L., Barbi, J. & Pan, F. The regulation of immune tolerance by FOXP3. Nat. Rev. Immunol. 17, 703\u2013717 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"994_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","volume":"34","author":"M Panduro","year":"2016","unstructured":"Panduro, M., Benoist, C. & Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609\u2013633 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"994_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899\u2013911 (2009).","journal-title":"Immunity"},{"key":"994_CR4","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1182\/blood-2011-11-392324","volume":"119","author":"T Duhen","year":"2012","unstructured":"Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F. & Campbell, D. J. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector TH cells. Blood 119, 4430\u20134440 (2012).","journal-title":"Blood"},{"key":"994_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.celrep.2017.06.079","volume":"20","author":"L Halim","year":"2017","unstructured":"Halim, L. et al. An atlas of human regulatory T helper-like cells reveals features of TH2-like Tregs that support a tumorigenic environment. Cell Rep. 20, 757\u2013770 (2017).","journal-title":"Cell Rep."},{"key":"994_CR6","doi-asserted-by":"publisher","first-page":"1154575","DOI":"10.3389\/fimmu.2023.1154575","volume":"14","author":"N Cheru","year":"2023","unstructured":"Cheru, N., Hafler, D. A. & Sumida, T. S. Regulatory T cells in peripheral tissue tolerance and diseases. Front. Immunol. 14, 1154575 (2023).","journal-title":"Front. Immunol."},{"key":"994_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523\u2013532 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"994_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","volume":"21","author":"S Sakaguchi","year":"2009","unstructured":"Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. & Yamaguchi, T. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105\u20131111 (2009).","journal-title":"Int. Immunol."},{"key":"994_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","volume":"3","author":"A Schmidt","year":"2012","unstructured":"Schmidt, A., Oberle, N. & Krammer, P. H. Molecular mechanisms of Treg-mediated T cell suppression. Front. Immunol. 3, 51 (2012).","journal-title":"Front. Immunol."},{"key":"994_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41577-023-00893-7","volume":"23","author":"JL Trujillo-Ochoa","year":"2023","unstructured":"Trujillo-Ochoa, J. L., Kazemian, M. & Afzali, B. The role of transcription factors in shaping regulatory T cell identity. Nat. Rev. Immunol. 23, 842\u2013856 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"994_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nm.3411","volume":"20","author":"F Carbone","year":"2014","unstructured":"Carbone, F. et al. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20, 69\u201374 (2014).","journal-title":"Nat. Med."},{"key":"994_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0010-y","volume":"8","author":"K John","year":"2017","unstructured":"John, K. et al. Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis. Cell Death Dis. 8, 3219 (2017).","journal-title":"Cell Death Dis."},{"key":"994_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","volume":"27","author":"ME Brunkow","year":"2001","unstructured":"Brunkow, M. E. et al. Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68\u201373 (2001).","journal-title":"Nat. Genet."},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin, R. S. et al. X-Linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18\u201320 (2001).","journal-title":"Nat. Genet."},{"key":"994_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta, V., Baecher-Allan, C., Weiner, H. L. & Hafler, D. A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971\u2013979 (2004).","journal-title":"J. Exp. Med."},{"key":"994_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nm.2389","volume":"17","author":"M Dominguez-Villar","year":"2011","unstructured":"Dominguez-Villar, M., Baecher-Allan, C. M. & Hafler, D. A. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673\u2013675 (2011).","journal-title":"Nat. Med."},{"key":"994_CR17","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.4049\/jimmunol.1002502","volume":"186","author":"CM Baecher-Allan","year":"2011","unstructured":"Baecher-Allan, C. M. et al. CD2 costimulation reveals defective activity by human CD4+CD25hi regulatory cells in patients with multiple sclerosis. J. Immunol. 186, 3317\u20133326 (2011).","journal-title":"J. Immunol."},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2337\/diabetes.54.5.1407","volume":"54","author":"TM Brusko","year":"2005","unstructured":"Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A. & Atkinson, M. A. Functional defects and the influence of age on the frequency of CD4+CD25+ T-cells in type 1 diabetes. Diabetes 54, 1407\u20131414 (2005).","journal-title":"Diabetes"},{"key":"994_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","volume":"54","author":"S Lindley","year":"2005","unstructured":"Lindley, S. et al. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 54, 92\u201399 (2005).","journal-title":"Diabetes"},{"key":"994_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/cei.12116","volume":"173","author":"F Haseda","year":"2013","unstructured":"Haseda, F., Imagawa, A., Murase-Mishiba, Y., Terasaki, J. & Hanafusa, T. CD4+CD45RA\u2013FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes. Clin. Exp. Immunol. 173, 207\u2013216 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"994_CR21","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/rheumatology\/keq237","volume":"49","author":"JA van Roon","year":"2010","unstructured":"van Roon, J. A., Hartgring, S. A., van der Wurff-Jacobs, K. M., Bijlsma, J. W. & Lafeber, F. P. Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients. Rheumatology 49, 2084\u20132089 (2010).","journal-title":"Rheumatology"},{"key":"994_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis. Nat. Med. 19, 322\u2013328 (2013).","journal-title":"Nat. Med."},{"key":"994_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/intimm\/dxn044","volume":"20","author":"M Bonelli","year":"2008","unstructured":"Bonelli, M. et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20, 861\u2013868 (2008).","journal-title":"Int. Immunol."},{"key":"994_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nri3155","volume":"12","author":"CS Hsieh","year":"2012","unstructured":"Hsieh, C. S., Lee, H. M. & Lio, C. W. Selection of regulatory T cells in the thymus. Nat. Rev. Immunol. 12, 157\u2013167 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"994_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature10434","volume":"478","author":"SK Lathrop","year":"2011","unstructured":"Lathrop, S. K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250\u2013254 (2011).","journal-title":"Nature"},{"key":"994_CR26","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen, W. et al. Conversion of peripheral CD4+CD25\u2013 naive T cells to CD4+CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3. J. Exp. Med. 198, 1875\u20131886 (2003).","journal-title":"J. Exp. Med."},{"key":"994_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","volume":"37","author":"M Kanamori","year":"2016","unstructured":"Kanamori, M., Nakatsukasa, H., Okada, M., Lu, Q. & Yoshimura, A. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 37, 803\u2013811 (2016).","journal-title":"Trends Immunol."},{"key":"994_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.immuni.2007.09.010","volume":"27","author":"JA Hill","year":"2007","unstructured":"Hill, J. A. et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27, 786\u2013800 (2007).","journal-title":"Immunity"},{"key":"994_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/intimm\/dxm014","volume":"19","author":"SE Allan","year":"2007","unstructured":"Allan, S. E. et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19, 345\u2013354 (2007).","journal-title":"Int. Immunol."},{"key":"994_CR30","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","volume":"110","author":"DQ Tran","year":"2007","unstructured":"Tran, D. Q., Ramsey, H. & Shevach, E. M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-\u03b2 dependent but does not confer a regulatory phenotype. Blood 110, 2983\u20132990 (2007).","journal-title":"Blood"},{"key":"994_CR31","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433\u20133441 (2010).","journal-title":"J. Immunol."},{"key":"994_CR32","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1084\/jem.20120914","volume":"209","author":"JM Weiss","year":"2012","unstructured":"Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ Treg cells. J. Exp. Med. 209, 1723\u20131742, S1 (2012).","journal-title":"J. Exp. Med."},{"key":"994_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141161","volume":"10","author":"E Szurek","year":"2015","unstructured":"Szurek, E. et al. Differences in expression level of helios and neuropilin-1 do not distinguish thymus-derived from extrathymically-induced CD4+Foxp3+ regulatory T cells. PLoS ONE 10, e0141161 (2015).","journal-title":"PLoS ONE"},{"key":"994_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2016.00276","volume":"7","author":"E Elkord","year":"2016","unstructured":"Elkord, E. Helios should not be cited as a marker of human thymus-derived Tregs. Commentary: Helios+ and Helios\u2013 cells coexist within the natural FOXP3+ T regulatory cell subset in humans. Front. Immunol. 7, 276 (2016).","journal-title":"Front. Immunol."},{"key":"994_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.immuni.2011.03.029","volume":"35","author":"D Haribhai","year":"2011","unstructured":"Haribhai, D. et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35, 109\u2013122 (2011).","journal-title":"Immunity"},{"key":"994_CR36","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20091999","volume":"207","author":"RA Gottschalk","year":"2010","unstructured":"Gottschalk, R. A., Corse, E. & Allison, J. P. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207, 1701\u20131711 (2010).","journal-title":"J. Exp. Med."},{"key":"994_CR37","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.4049\/jimmunol.0901459","volume":"183","author":"MS Turner","year":"2009","unstructured":"Turner, M. S., Kane, L. P. & Morel, P. A. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. J. Immunol. 183, 4895\u20134903 (2009).","journal-title":"J. Immunol."},{"key":"994_CR38","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/eji.201041073","volume":"41","author":"L Gabrysova","year":"2011","unstructured":"Gabrysova, L. et al. Integrated T-cell receptor and costimulatory signals determine TGF-\u03b2-dependent differentiation and maintenance of Foxp3+ regulatory T cells. Eur. J. Immunol. 41, 1242\u20131248 (2011).","journal-title":"Eur. J. Immunol."},{"key":"994_CR39","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl Acad. Sci. USA 105, 7797\u20137802 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4049\/jimmunol.1700369","volume":"199","author":"WF Hawse","year":"2017","unstructured":"Hawse, W. F., Boggess, W. C. & Morel, P. A. TCR signal strength regulates Akt substrate specificity to induce alternate murine TH and T regulatory cell differentiation programs. J. Immunol. 199, 589\u2013597 (2017).","journal-title":"J. Immunol."},{"key":"994_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.20071477","volume":"205","author":"S Haxhinasto","year":"2008","unstructured":"Haxhinasto, S., Mathis, D. & Benoist, C. The AKT\u2013mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565\u2013574 (2008).","journal-title":"J. Exp. Med."},{"key":"994_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ni1437","volume":"8","author":"LM Williams","year":"2007","unstructured":"Williams, L. M. & Rudensky, A. Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277\u2013284 (2007).","journal-title":"Nat. Immunol."},{"key":"994_CR43","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ni.1774","volume":"10","author":"X Zhou","year":"2009","unstructured":"Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000\u20131007 (2009).","journal-title":"Nat. Immunol."},{"key":"994_CR44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","volume":"36","author":"T Miyao","year":"2012","unstructured":"Miyao, T. et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262\u2013275 (2012).","journal-title":"Immunity"},{"key":"994_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10772","volume":"482","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz, S. Z. et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395\u2013399 (2012).","journal-title":"Nature"},{"key":"994_CR46","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.1191996","volume":"329","author":"YP Rubtsov","year":"2010","unstructured":"Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667\u20131671 (2010).","journal-title":"Science"},{"key":"994_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nature05543","volume":"445","author":"MA Gavin","year":"2007","unstructured":"Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771\u2013775 (2007).","journal-title":"Nature"},{"key":"994_CR48","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nature05479","volume":"445","author":"YY Wan","year":"2007","unstructured":"Wan, Y. Y. & Flavell, R. A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766\u2013770 (2007).","journal-title":"Nature"},{"key":"994_CR49","doi-asserted-by":"publisher","first-page":"109494","DOI":"10.1016\/j.celrep.2021.109494","volume":"36","author":"AJ Lam","year":"2021","unstructured":"Lam, A. J. et al. Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity. Cell Rep. 36, 109494 (2021).","journal-title":"Cell Rep."},{"key":"994_CR50","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.immuni.2022.05.010","volume":"55","author":"J van der Veeken","year":"2022","unstructured":"van der Veeken, J. et al. Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells. Immunity 55, 1173\u20131184.e7 (2022).","journal-title":"Immunity"},{"key":"994_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/ni1549","volume":"9","author":"Y Tone","year":"2008","unstructured":"Tone, Y. et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194\u2013202 (2008).","journal-title":"Nat. Immunol."},{"key":"994_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature08750","volume":"463","author":"Y Zheng","year":"2010","unstructured":"Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808\u2013812 (2010).","journal-title":"Nature"},{"key":"994_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217728","volume":"14","author":"DR Holohan","year":"2019","unstructured":"Holohan, D. R., Van Gool, F. & Bluestone, J. A. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model. PLoS ONE 14, e0217728 (2019).","journal-title":"PLoS ONE"},{"key":"994_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK Farh","year":"2015","unstructured":"Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337\u2013343 (2015).","journal-title":"Nature"},{"key":"994_CR55","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.immuni.2020.04.006","volume":"52","author":"N Ohkura","year":"2020","unstructured":"Ohkura, N. et al. Regulatory T cell-specific epigenomic region variants are a key determinant of susceptibility to common autoimmune diseases. Immunity 52, 1119\u20131132.e4 (2020).","journal-title":"Immunity"},{"key":"994_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fimmu.2012.00113","volume":"3","author":"KG Andersen","year":"2012","unstructured":"Andersen, K. G., Nissen, J. K. & Betz, A. G. Comparative genomics reveals key gain-of-function events in Foxp3 during regulatory T cell evolution. Front. Immunol. 3, 113 (2012).","journal-title":"Front. Immunol."},{"key":"994_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005251","volume":"11","author":"X Xie","year":"2015","unstructured":"Xie, X. et al. The regulatory T cell lineage factor Foxp3 regulates gene expression through several distinct mechanisms mostly independent of direct DNA binding. PLoS Genet. 11, e1005251 (2015).","journal-title":"PLoS Genet."},{"key":"994_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.313","volume":"50","author":"W Lee","year":"2018","unstructured":"Lee, W. & Lee, G. R. Transcriptional regulation and development of regulatory T cells. Exp. Mol. Med. 50, e456 (2018).","journal-title":"Exp. Mol. Med."},{"key":"994_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ni.3646","volume":"18","author":"Y Kitagawa","year":"2017","unstructured":"Kitagawa, Y. et al. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat. Immunol. 18, 173\u2013183 (2017).","journal-title":"Nat. Immunol."},{"key":"994_CR60","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ni.3812","volume":"18","author":"K Placek","year":"2017","unstructured":"Placek, K. et al. MLL4 prepares the enhancer landscape for Foxp3 induction via chromatin looping. Nat. Immunol. 18, 1035\u20131045 (2017).","journal-title":"Nat. Immunol."},{"key":"994_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.immuni.2020.06.011","volume":"53","author":"CS Loo","year":"2020","unstructured":"Loo, C. S. et al. A genome-wide CRISPR screen reveals a role for the non-canonical nucleosome-remodeling BAF complex in Foxp3 expression and regulatory T cell function. Immunity 53, 143\u2013157 e148 (2020).","journal-title":"Immunity"},{"key":"994_CR62","doi-asserted-by":"publisher","first-page":"eaaw2707","DOI":"10.1126\/sciimmunol.aaw2707","volume":"4","author":"M Akamatsu","year":"2019","unstructured":"Akamatsu, M. et al. Conversion of antigen-specific effector\/memory T cells into Foxp3-expressing Treg cells by inhibition of CDK8\/19. Sci. Immunol. 4, eaaw2707 (2019).","journal-title":"Sci. Immunol."},{"key":"994_CR63","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2021.03.020","volume":"54","author":"S Dikiy","year":"2021","unstructured":"Dikiy, S. et al. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance. Immunity 54, 931\u2013946.e11 (2021).","journal-title":"Immunity"},{"key":"994_CR64","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/eji.201847498","volume":"48","author":"C Schuster","year":"2018","unstructured":"Schuster, C., Jonas, F., Zhao, F. & Kissler, S. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model. Eur. J. Immunol. 48, 1211\u20131216 (2018).","journal-title":"Eur. J. Immunol."},{"key":"994_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S Floess","year":"2007","unstructured":"Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).","journal-title":"PLoS Biol."},{"key":"994_CR66","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1084\/jem.20070109","volume":"204","author":"HP Kim","year":"2007","unstructured":"Kim, H. P. & Leonard, W. J. CREB\/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204, 1543\u20131551 (2007).","journal-title":"J. Exp. Med."},{"key":"994_CR67","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.4049\/jimmunol.1100061","volume":"186","author":"Q Chen","year":"2011","unstructured":"Chen, Q., Kim, Y. C., Laurence, A., Punkosdy, G. A. & Shevach, E. M. IL-2 controls the stability of Foxp3 expression in TGF-\u03b2-induced Foxp3+ T cells in vivo. J. Immunol. 186, 6329\u20136337 (2011).","journal-title":"J. Immunol."},{"key":"994_CR68","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2014.07.030","volume":"158","author":"X Li","year":"2014","unstructured":"Li, X., Liang, Y., LeBlanc, M., Benner, C. & Zheng, Y. Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell 158, 734\u2013748 (2014).","journal-title":"Cell"},{"key":"994_CR69","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ni.1795","volume":"10","author":"D Rudra","year":"2009","unstructured":"Rudra, D. et al. Runx-CBF\u03b2 complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10, 1170\u20131177 (2009).","journal-title":"Nat. Immunol."},{"key":"994_CR70","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.immuni.2009.09.003","volume":"31","author":"A Kitoh","year":"2009","unstructured":"Kitoh, A. et al. Indispensable role of the Runx1\u2013Cbf\u03b2 transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 31, 609\u2013620 (2009).","journal-title":"Immunity"},{"key":"994_CR71","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1128\/MCB.00144-13","volume":"33","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function. Mol. Cell Biol. 33, 4106\u20134115 (2013).","journal-title":"Mol. Cell Biol."},{"key":"994_CR72","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2014.07.031","volume":"158","author":"Y Feng","year":"2014","unstructured":"Feng, Y. et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell 158, 749\u2013763 (2014).","journal-title":"Cell"},{"key":"994_CR73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smim.2015.02.002","volume":"27","author":"J Huehn","year":"2015","unstructured":"Huehn, J. & Beyer, M. Epigenetic and transcriptional control of Foxp3+ regulatory T cells. Semin. Immunol. 27, 10\u201318 (2015).","journal-title":"Semin. Immunol."},{"key":"994_CR74","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nature16141","volume":"528","author":"Y Feng","year":"2015","unstructured":"Feng, Y. et al. A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature 528, 132\u2013136 (2015).","journal-title":"Nature"},{"key":"994_CR75","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2021.04.005","volume":"54","author":"R Kawakami","year":"2021","unstructured":"Kawakami, R. et al. Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells. Immunity 54, 947\u2013961.e8 (2021).","journal-title":"Immunity"},{"key":"994_CR76","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","volume":"37","author":"N Ohkura","year":"2012","unstructured":"Ohkura, N. et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785\u2013799 (2012).","journal-title":"Immunity"},{"key":"994_CR77","doi-asserted-by":"publisher","first-page":"609891","DOI":"10.3389\/fimmu.2020.609891","volume":"11","author":"C Kressler","year":"2020","unstructured":"Kressler, C. et al. Targeted de-methylation of the FOXP3-TSDR is sufficient to induce physiological FOXP3 expression but not a functional Treg phenotype. Front. Immunol. 11, 609891 (2020).","journal-title":"Front. Immunol."},{"key":"994_CR78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13072-017-0129-1","volume":"10","author":"M Okada","year":"2017","unstructured":"Okada, M., Kanamori, M., Someya, K., Nakatsukasa, H. & Yoshimura, A. Stabilization of Foxp3 expression by CRISPR\u2013dCas9-based epigenome editing in mouse primary T cells. Epigenetics Chromatin 10, 24 (2017).","journal-title":"Epigenetics Chromatin"},{"key":"994_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32\u201342 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"994_CR80","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1128\/MCB.05155-11","volume":"31","author":"EF de Zoeten","year":"2011","unstructured":"de Zoeten, E. F. et al. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3+ T-regulatory cells. Mol. Cell Biol. 31, 2066\u20132078 (2011).","journal-title":"Mol. Cell Biol."},{"key":"994_CR81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaut.2019.02.007","volume":"100","author":"Q Su","year":"2019","unstructured":"Su, Q. et al. Impaired Tip60-mediated Foxp3 acetylation attenuates regulatory T cell development in rheumatoid arthritis. J. Autoimmun. 100, 27\u201339 (2019).","journal-title":"J. Autoimmun."},{"key":"994_CR82","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1652","volume":"13","author":"R Tao","year":"2007","unstructured":"Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299\u20131307 (2007).","journal-title":"Nat. Med."},{"key":"994_CR83","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/j.gastro.2009.10.037","volume":"138","author":"EF de Zoeten","year":"2010","unstructured":"de Zoeten, E. F., Wang, L., Sai, H., Dillmann, W. H. & Hancock, W. W. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138, 583\u2013594 (2010).","journal-title":"Gastroenterology"},{"key":"994_CR84","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2002873","volume":"5","author":"UH Beier","year":"2012","unstructured":"Beier, U. H. et al. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci. Signal. 5, ra45 (2012).","journal-title":"Sci. Signal."},{"key":"994_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57294-x","volume":"10","author":"S Dahiya","year":"2020","unstructured":"Dahiya, S. et al. HDAC10 deletion promotes Foxp3+ T-regulatory cell function. Sci. Rep. 10, 424 (2020).","journal-title":"Sci. Rep."},{"key":"994_CR86","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1128\/MCB.01206-10","volume":"31","author":"UH Beier","year":"2011","unstructured":"Beier, U. H. et al. Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. Mol. Cell Biol. 31, 1022\u20131029 (2011).","journal-title":"Mol. Cell Biol."},{"key":"994_CR87","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI77088","volume":"125","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. FOXP3+ regulatory T cell development and function require histone\/protein deacetylase 3. J. Clin. Invest. 125, 1111\u20131123 (2015).","journal-title":"J. Clin. Invest."},{"key":"994_CR88","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1002\/ijc.29979","volume":"138","author":"H Xiao","year":"2016","unstructured":"Xiao, H. et al. HDAC5 controls the functions of Foxp3+ T-regulatory and CD8+ T cells. Int. J. Cancer 138, 2477\u20132486 (2016).","journal-title":"Int. J. Cancer"},{"key":"994_CR89","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1096\/fj.14-268409","volume":"29","author":"UH Beier","year":"2015","unstructured":"Beier, U. H. et al. Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival. FASEB J. 29, 2315\u20132326 (2015).","journal-title":"FASEB J."},{"key":"994_CR90","doi-asserted-by":"publisher","first-page":"16597","DOI":"10.1074\/jbc.C000909200","volume":"276","author":"HJ Lee","year":"2001","unstructured":"Lee, H. J., Chun, M. & Kandror, K. V. Tip60 and HDAC7 interact with the endothelin receptor A and may be involved in downstream signaling. J. Biol. Chem. 276, 16597\u201316600 (2001).","journal-title":"J. Biol. Chem."},{"key":"994_CR91","doi-asserted-by":"publisher","first-page":"eabl3651","DOI":"10.1126\/scitranslmed.abl3651","volume":"14","author":"PP Axisa","year":"2022","unstructured":"Axisa, P. P. et al. A multiple sclerosis-protective coding variant reveals an essential role for HDAC7 in regulatory T cells. Sci. Transl Med. 14, eabl3651 (2022).","journal-title":"Sci. Transl Med."},{"key":"994_CR92","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.cell.2018.09.049","volume":"175","author":"International Multiple Sclerosis Genetics Consortium.","year":"2018","unstructured":"International Multiple Sclerosis Genetics Consortium. Low-frequency and rare-coding variation contributes to multiple sclerosis risk. Cell 175, 1679\u20131687.e7 (2018).","journal-title":"Cell"},{"key":"994_CR93","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1172\/JCI135486","volume":"130","author":"E Di Giorgio","year":"2020","unstructured":"Di Giorgio, E. et al. MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity. J. Clin. Invest. 130, 6242\u20136260 (2020).","journal-title":"J. Clin. Invest."},{"key":"994_CR94","doi-asserted-by":"publisher","first-page":"703632","DOI":"10.3389\/fimmu.2021.703632","volume":"12","author":"E Di Giorgio","year":"2021","unstructured":"Di Giorgio, E. et al. A biological circuit involving Mef2c, Mef2d, and Hdac9 controls the immunosuppressive functions of CD4+Foxp3+ T-regulatory cells. Front. Immunol. 12, 703632 (2021).","journal-title":"Front. Immunol."},{"key":"994_CR95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343\u2013349 (2011).","journal-title":"Nature"},{"key":"994_CR96","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nature05563","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936\u2013940 (2007).","journal-title":"Nature"},{"key":"994_CR97","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/ni.2402","volume":"13","author":"D Rudra","year":"2012","unstructured":"Rudra, D. et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 13, 1010\u20131019 (2012).","journal-title":"Nat. Immunol."},{"key":"994_CR98","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ni.2868","volume":"15","author":"A Arvey","year":"2014","unstructured":"Arvey, A. et al. Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 15, 580\u2013587 (2014).","journal-title":"Nat. Immunol."},{"key":"994_CR99","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.immuni.2015.01.007","volume":"42","author":"M DuPage","year":"2015","unstructured":"DuPage, M. et al. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation. Immunity 42, 227\u2013238 (2015).","journal-title":"Immunity"},{"key":"994_CR100","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jcmgh.2018.08.009","volume":"7","author":"AO Bamidele","year":"2019","unstructured":"Bamidele, A. O. et al. Disruption of FOXP3\u2013EZH2 interaction represents a pathobiological mechanism in intestinal inflammation. Cell Mol. Gastroenterol. Hepatol. 7, 55\u201371 (2019).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"994_CR101","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano, T. IL-6 in inflammation, autoimmunity and cancer. Int. Immunol. 33, 127\u2013148 (2021).","journal-title":"Int. Immunol."},{"key":"994_CR102","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1084\/jem.20181134","volume":"216","author":"S Hou","year":"2019","unstructured":"Hou, S. et al. FoxP3 and Ezh2 regulate TFR cell suppressive function and transcriptional program. J. Exp. Med. 216, 605\u2013620 (2019).","journal-title":"J. Exp. Med."},{"key":"994_CR103","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.immuni.2013.09.012","volume":"39","author":"DJ Tumes","year":"2013","unstructured":"Tumes, D. J. et al. The polycomb protein Ezh2 regulates differentiation and plasticity of CD4+ T helper type 1 and type 2 cells. Immunity 39, 819\u2013832 (2013).","journal-title":"Immunity"},{"key":"994_CR104","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41586-020-2246-4","volume":"582","author":"JT Cortez","year":"2020","unstructured":"Cortez, J. T. et al. CRISPR screen in regulatory T cells reveals modulators of Foxp3. Nature 582, 416\u2013420 (2020).","journal-title":"Nature"},{"key":"994_CR105","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cell.2012.06.053","volume":"151","author":"RM Samstein","year":"2012","unstructured":"Samstein, R. M. et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153\u2013166 (2012).","journal-title":"Cell"},{"key":"994_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000270","volume":"17","author":"J Ren","year":"2019","unstructured":"Ren, J. et al. Foxp1 is critical for the maintenance of regulatory T-cell homeostasis and suppressive function. PLoS Biol. 17, e3000270 (2019).","journal-title":"PLoS Biol."},{"key":"994_CR107","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41590-018-0291-z","volume":"20","author":"C Konopacki","year":"2019","unstructured":"Konopacki, C., Pritykin, Y., Rubtsov, Y., Leslie, C. S. & Rudensky, A. Y. Transcription factor Foxp1 regulates Foxp3 chromatin binding and coordinates regulatory T cell function. Nat. Immunol. 20, 232\u2013242 (2019).","journal-title":"Nat. Immunol."},{"key":"994_CR108","doi-asserted-by":"publisher","first-page":"E1111","DOI":"10.1073\/pnas.1401343111","volume":"111","author":"A Ferraro","year":"2014","unstructured":"Ferraro, A. et al. Interindividual variation in human T regulatory cells. Proc. Natl Acad. Sci. USA 111, E1111\u2013E1120 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR109","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ni.3835","volume":"18","author":"HK Kwon","year":"2017","unstructured":"Kwon, H. K., Chen, H. M., Mathis, D. & Benoist, C. Different molecular complexes that mediate transcriptional induction and repression by FoxP3. Nat. Immunol. 18, 1238\u20131248 (2017).","journal-title":"Nat. Immunol."},{"key":"994_CR110","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/ng.3963","volume":"49","author":"MR Mumbach","year":"2017","unstructured":"Mumbach, M. R. et al. Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat. Genet. 49, 1602\u20131612 (2017).","journal-title":"Nat. Genet."},{"key":"994_CR111","first-page":"eabj9836","volume":"7","author":"RN Ramirez","year":"2022","unstructured":"Ramirez, R. N., Chowdhary, K., Leon, J., Mathis, D. & Benoist, C. FoxP3 associates with enhancer-promoter loops to regulate Treg-specific gene expression. Sci. Immunol. 7, eabj9836 (2022).","journal-title":"Sci. Immunol."},{"key":"994_CR112","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2020.10.010","volume":"53","author":"J van der Veeken","year":"2020","unstructured":"van der Veeken, J. et al. The transcription factor Foxp3 shapes regulatory T cell identity by tuning the activity of trans-acting intermediaries. Immunity 53, 971\u2013984.e5 (2020).","journal-title":"Immunity"},{"key":"994_CR113","doi-asserted-by":"publisher","unstructured":"Ramirez, R. N., Chowdhary, K., Leon, J., Mathis, D. & Benoist, C. FoxP3 associates with enhancer-promoter loops to regulate Treg-specific gene expression. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.11.12.468430 (2021).","DOI":"10.1101\/2021.11.12.468430"},{"key":"994_CR114","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1016\/j.celrep.2019.05.061","volume":"27","author":"BH Yang","year":"2019","unstructured":"Yang, B. H. et al. TCF1 and LEF1 control Treg competitive survival and TFR development to prevent autoimmune diseases. Cell Rep. 27, 3629\u20133645.e6 (2019).","journal-title":"Cell Rep."},{"key":"994_CR115","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220386","volume":"220","author":"A Tanaka","year":"2023","unstructured":"Tanaka, A. et al. Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease. J. Exp. Med. 220, e20220386 (2023).","journal-title":"J. Exp. Med."},{"key":"994_CR116","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ni.3004","volume":"15","author":"AG Levine","year":"2014","unstructured":"Levine, A. G., Arvey, A., Jin, W. & Rudensky, A. Y. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15, 1070\u20131078 (2014).","journal-title":"Nat. Immunol."},{"key":"994_CR117","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.immuni.2014.10.012","volume":"41","author":"JC Vahl","year":"2014","unstructured":"Vahl, J. C. et al. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity 41, 722\u2013736 (2014).","journal-title":"Immunity"},{"key":"994_CR118","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature16169","volume":"528","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Immune homeostasis enforced by co-localized effector and regulatory T cells. Nature 528, 225\u2013230 (2015).","journal-title":"Nature"},{"key":"994_CR119","doi-asserted-by":"publisher","unstructured":"Dikiy, S. et al. Terminal differentiation and persistence of effector regulatory T cells essential for the prevention of intestinal inflammation. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.05.16.492030 (2023).","DOI":"10.1101\/2022.05.16.492030"},{"key":"994_CR120","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature22360","volume":"546","author":"AG Levine","year":"2017","unstructured":"Levine, A. G. et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546, 421\u2013425 (2017).","journal-title":"Nature"},{"key":"994_CR121","doi-asserted-by":"publisher","first-page":"112813","DOI":"10.1016\/j.celrep.2023.112813","volume":"42","author":"M Okamoto","year":"2023","unstructured":"Okamoto, M. et al. A genetic method specifically delineates TH1-type Treg cells and their roles in tumor immunity. Cell Rep. 42, 112813 (2023).","journal-title":"Cell Rep."},{"key":"994_CR122","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","volume":"40","author":"N Joller","year":"2014","unstructured":"Joller, N. et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory TH1 and TH17 cell responses. Immunity 40, 569\u2013581 (2014).","journal-title":"Immunity"},{"key":"994_CR123","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","volume":"44","author":"AC Anderson","year":"2016","unstructured":"Anderson, A. C., Joller, N. & Kuchroo, V. K. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity 44, 989\u20131004 (2016).","journal-title":"Immunity"},{"key":"994_CR124","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/mi.2015.74","volume":"9","author":"BH Yang","year":"2016","unstructured":"Yang, B. H. et al. Foxp3+ T cells expressing ROR\u03b3t represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 9, 444\u2013457 (2016).","journal-title":"Mucosal Immunol."},{"key":"994_CR125","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986\u2013991 (2009).","journal-title":"Science"},{"key":"994_CR126","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.aaa9420","volume":"349","author":"E Sefik","year":"2015","unstructured":"Sefik, E. et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of ROR\u03b3+ regulatory T cells. Science 349, 993\u2013997 (2015).","journal-title":"Science"},{"key":"994_CR127","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.4049\/jimmunol.2100175","volume":"207","author":"S Bhaumik","year":"2021","unstructured":"Bhaumik, S., Mickael, M. E., Moran, M., Spell, M. & Basu, R. ROR\u03b3t promotes Foxp3 expression by antagonizing the effector program in colonic regulatory T cells. J. Immunol. 207, 2027\u20132038 (2021).","journal-title":"J. Immunol."},{"key":"994_CR128","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature07674","volume":"458","author":"Y Zheng","year":"2009","unstructured":"Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 458, 351\u2013356 (2009).","journal-title":"Nature"},{"key":"994_CR129","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4049\/jimmunol.1300486","volume":"191","author":"NJ Dorsey","year":"2013","unstructured":"Dorsey, N. J. et al. STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation. J. Immunol. 191, 1517\u20131528 (2013).","journal-title":"J. Immunol."},{"key":"994_CR130","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.immuni.2011.08.012","volume":"35","author":"Y Wang","year":"2011","unstructured":"Wang, Y., Su, M. A. & Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337\u2013348 (2011).","journal-title":"Immunity"},{"key":"994_CR131","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1172\/JCI57456","volume":"121","author":"EA Wohlfert","year":"2011","unstructured":"Wohlfert, E. A. et al. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503\u20134515 (2011).","journal-title":"J. Clin. Invest."},{"key":"994_CR132","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ni.3053","volume":"16","author":"F Yu","year":"2015","unstructured":"Yu, F., Sharma, S., Edwards, J., Feigenbaum, L. & Zhu, J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat. Immunol. 16, 197\u2013206 (2015).","journal-title":"Nat. Immunol."},{"key":"994_CR133","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","volume":"31","author":"G Oldenhove","year":"2009","unstructured":"Oldenhove, G. et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772\u2013786 (2009).","journal-title":"Immunity"},{"key":"994_CR134","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.3389\/fimmu.2019.02158","volume":"10","author":"M Di Giovangiulio","year":"2019","unstructured":"Di Giovangiulio, M. et al. Tbet expression in regulatory T cells is required to initiate TH1-mediated colitis. Front. Immunol. 10, 2158 (2019).","journal-title":"Front. Immunol."},{"key":"994_CR135","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1073\/pnas.0900408106","volume":"106","author":"KS Voo","year":"2009","unstructured":"Voo, K. S. et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl Acad. Sci. USA 106, 4793\u20134798 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR136","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.4049\/jimmunol.1303257","volume":"194","author":"S Bhela","year":"2015","unstructured":"Bhela, S. et al. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J. Immunol. 194, 2180\u20132189 (2015).","journal-title":"J. Immunol."},{"key":"994_CR137","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41590-018-0236-6","volume":"19","author":"T Sumida","year":"2018","unstructured":"Sumida, T. et al. Activated \u03b2-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity. Nat. Immunol. 19, 1391\u20131402 (2018).","journal-title":"Nat. Immunol."},{"key":"994_CR138","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","volume":"186","author":"SA McClymont","year":"2011","unstructured":"McClymont, S. A. et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918\u20133926 (2011).","journal-title":"J. Immunol."},{"key":"994_CR139","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","volume":"169","author":"AE Overacre-Delgoffe","year":"2017","unstructured":"Overacre-Delgoffe, A. E. et al. Interferon-\u03b3 drives Treg fragility to promote anti-tumor immunity. Cell 169, 1130\u20131141.e11 (2017).","journal-title":"Cell"},{"key":"994_CR140","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1158\/2326-6066.CIR-22-0295","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. Protection of regulatory T cells from fragility and inactivation in the tumor microenvironment. Cancer Immunol. Res. 10, 1490\u20131505 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"994_CR141","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.4049\/jimmunol.1701134","volume":"199","author":"JD Wheaton","year":"2017","unstructured":"Wheaton, J. D., Yeh, C. H. & Ciofani, M. Cutting edge: c-Maf is required for regulatory T cells to adopt ROR\u03b3t+ and follicular phenotypes. J. Immunol. 199, 3931\u20133936 (2017).","journal-title":"J. Immunol."},{"key":"994_CR142","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.15252\/embr.201541905","volume":"17","author":"A Kitz","year":"2016","unstructured":"Kitz, A. et al. AKT isoforms modulate TH1-like Treg generation and function in human autoimmune disease. EMBO Rep. 17, 1169\u20131183 (2016).","journal-title":"EMBO Rep."},{"key":"994_CR143","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1222794","volume":"337","author":"MT Maurano","year":"2012","unstructured":"Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190\u20131195 (2012).","journal-title":"Science"},{"key":"994_CR144","doi-asserted-by":"crossref","unstructured":"Lucca, L. E. et al. TIGIT signaling restores suppressor function of TH1 Tregs. JCI Insight 4, e124427 (2019).","DOI":"10.1172\/jci.insight.124427"},{"key":"994_CR145","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1152\/physiol.00053.2004","volume":"20","author":"JA McCormick","year":"2005","unstructured":"McCormick, J. A., Bhalla, V., Pao, A. C. & Pearce, D. SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption. Physiology 20, 134\u2013139 (2005).","journal-title":"Physiology"},{"key":"994_CR146","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature11984","volume":"496","author":"C Wu","year":"2013","unstructured":"Wu, C. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513\u2013517 (2013).","journal-title":"Nature"},{"key":"994_CR147","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature11868","volume":"496","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld, M. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518\u2013522 (2013).","journal-title":"Nature"},{"key":"994_CR148","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1172\/JCI81151","volume":"125","author":"AL Hernandez","year":"2015","unstructured":"Hernandez, A. L. et al. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J. Clin. Invest. 125, 4212\u20134222 (2015).","journal-title":"J. Clin. Invest."},{"key":"994_CR149","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.celrep.2017.12.068","volume":"22","author":"C Wu","year":"2018","unstructured":"Wu, C. et al. SGK1 governs the reciprocal development of TH17 and regulatory T cells. Cell Rep. 22, 653\u2013665 (2018).","journal-title":"Cell Rep."},{"key":"994_CR150","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1210\/me.2009-0265","volume":"24","author":"N Di Pietro","year":"2010","unstructured":"Di Pietro, N. et al. Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1. Mol. Endocrinol. 24, 370\u2013380 (2010).","journal-title":"Mol. Endocrinol."},{"key":"994_CR151","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/brain\/awt149","volume":"136","author":"D Paling","year":"2013","unstructured":"Paling, D. et al. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. Brain 136, 2305\u20132317 (2013).","journal-title":"Brain"},{"key":"994_CR152","doi-asserted-by":"publisher","unstructured":"Sumida, T. S. et al. An autoimmune transcriptional circuit driving Foxp3+ regulatory T cell dysfunction. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.12.02.518871 (2022).","DOI":"10.1101\/2022.12.02.518871"},{"key":"994_CR153","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni.2867","volume":"15","author":"EB Heikamp","year":"2014","unstructured":"Heikamp, E. B. et al. The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. Nat. Immunol. 15, 457\u2013464 (2014).","journal-title":"Nat. Immunol."},{"key":"994_CR154","doi-asserted-by":"publisher","first-page":"225ra228","DOI":"10.1126\/scitranslmed.3007607","volume":"6","author":"S Keerthivasan","year":"2014","unstructured":"Keerthivasan, S. et al. \u03b2-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci. Transl Med. 6, 225ra228 (2014).","journal-title":"Sci. Transl Med."},{"key":"994_CR155","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers, H. & Nusse, R. Wnt\/\u03b2-catenin signaling and disease. Cell 149, 1192\u20131205 (2012).","journal-title":"Cell"},{"key":"994_CR156","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1073\/pnas.1524660113","volume":"113","author":"F Depis","year":"2016","unstructured":"Depis, F., Kwon, H. K., Mathis, D. & Benoist, C. Unstable FoxP3+ T regulatory cells in NZW mice. Proc. Natl Acad. Sci. USA 113, 1345\u20131350 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR157","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow, M. K. Type I interferon in the pathogenesis of lupus. J. Immunol. 192, 5459\u20135468 (2014).","journal-title":"J. Immunol."},{"key":"994_CR158","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","volume":"184","author":"M Ota","year":"2021","unstructured":"Ota, M. et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 184, 3006\u20133021.e17 (2021).","journal-title":"Cell"},{"key":"994_CR159","doi-asserted-by":"publisher","first-page":"111606","DOI":"10.1016\/j.celrep.2022.111606","volume":"41","author":"C Guo","year":"2022","unstructured":"Guo, C. et al. Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus. Cell Rep. 41, 111606 (2022).","journal-title":"Cell Rep."},{"key":"994_CR160","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41590-022-01152-y","volume":"23","author":"TS Sumida","year":"2022","unstructured":"Sumida, T. S. et al. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells. Nat. Immunol. 23, 632\u2013642 (2022).","journal-title":"Nat. Immunol."},{"key":"994_CR161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006985","volume":"14","author":"A Gangaplara","year":"2018","unstructured":"Gangaplara, A. et al. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment. PLoS Pathog. 14, e1006985 (2018).","journal-title":"PLoS Pathog."},{"key":"994_CR162","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.4049\/jimmunol.1500036","volume":"194","author":"A Metidji","year":"2015","unstructured":"Metidji, A. et al. IFN-\u03b1\/\u03b2 receptor signaling promotes regulatory T cell development and function under stress conditions. J. Immunol. 194, 4265\u20134276 (2015).","journal-title":"J. Immunol."},{"key":"994_CR163","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.10.013","volume":"218","author":"A Namdar","year":"2010","unstructured":"Namdar, A., Nikbin, B., Ghabaee, M., Bayati, A. & Izad, M. Effect of IFN-\u03b2 therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing\u2013remitting multiple sclerosis (RRMS): a preliminary study. J. Neuroimmunol. 218, 120\u2013124 (2010).","journal-title":"J. Neuroimmunol."},{"key":"994_CR164","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4545","volume":"16","author":"B Moradi","year":"2014","unstructured":"Moradi, B. et al. CD4+CD25+\/highCD127low\/\u2013 regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints\u2014analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res. Ther. 16, R97 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"994_CR165","doi-asserted-by":"publisher","first-page":"R335","DOI":"10.1186\/ar1192","volume":"6","author":"D Cao","year":"2004","unstructured":"Cao, D., van Vollenhoven, R., Klareskog, L., Trollmo, C. & Malmstrom, V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6, R335\u2013R346 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"994_CR166","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/03009740701482800","volume":"36","author":"Z Jiao","year":"2007","unstructured":"Jiao, Z. et al. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand. J. Rheumatol. 36, 428\u2013433 (2007).","journal-title":"Scand. J. Rheumatol."},{"key":"994_CR167","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","volume":"140","author":"M Mottonen","year":"2005","unstructured":"Mottonen, M. et al. CD4+CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140, 360\u2013367 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"994_CR168","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s42003-021-02931-3","volume":"4","author":"D Simone","year":"2021","unstructured":"Simone, D. et al. Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates. Commun. Biol. 4, 1395 (2021).","journal-title":"Commun. Biol."},{"key":"994_CR169","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149185","volume":"6","author":"AM Jule","year":"2021","unstructured":"Jule, A. M. et al. TH1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. JCI Insight 6, e149185 (2021).","journal-title":"JCI Insight"},{"key":"994_CR170","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/eji.201243296","volume":"43","author":"B Afzali","year":"2013","unstructured":"Afzali, B. et al. CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur. J. Immunol. 43, 2043\u20132054 (2013).","journal-title":"Eur. J. Immunol."},{"key":"994_CR171","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/art.39606","volume":"68","author":"LA Henderson","year":"2016","unstructured":"Henderson, L. A. et al. Next-generation sequencing reveals restriction and clonotypic expansion of Treg cells in juvenile idiopathic arthritis. Arthritis Rheumatol. 68, 1758\u20131768 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"994_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1420","volume":"11","author":"L Lutter","year":"2022","unstructured":"Lutter, L. et al. Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint. Clin. Transl. Immunol. 11, e1420 (2022).","journal-title":"Clin. Transl. Immunol."},{"key":"994_CR173","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542, 110\u2013114 (2017).","journal-title":"Nature"},{"key":"994_CR174","doi-asserted-by":"publisher","first-page":"111895","DOI":"10.1016\/j.celrep.2022.111895","volume":"42","author":"H Asashima","year":"2023","unstructured":"Asashima, H. et al. PD-1highCXCR5\u2013CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection. Cell Rep. 42, 111895 (2023).","journal-title":"Cell Rep."},{"key":"994_CR175","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu, N. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62\u201368 (2014).","journal-title":"Nat. Med."},{"key":"994_CR176","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Ge","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019).","journal-title":"Science"},{"key":"994_CR177","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381 (2014).","journal-title":"Nature"},{"key":"994_CR178","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ajhg.2019.03.012","volume":"104","author":"T Amariuta","year":"2019","unstructured":"Amariuta, T. et al. IMPACT: genomic annotation of cell-state-specific regulatory elements inferred from the epigenome of bound transcription factors. Am. J. Hum. Genet. 104, 879\u2013895 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"994_CR179","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/ng.2504","volume":"45","author":"G Trynka","year":"2013","unstructured":"Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124\u2013130 (2013).","journal-title":"Nat. Genet."},{"key":"994_CR180","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrg2612","volume":"10","author":"TF Mackay","year":"2009","unstructured":"Mackay, T. F., Stone, E. A. & Ayroles, J. F. The genetics of quantitative traits: challenges and prospects. Nat. Rev. Genet. 10, 565\u2013577 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"994_CR181","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","volume":"175","author":"BJ Schmiedel","year":"2018","unstructured":"Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell 175, 1701\u20131715.e16 (2018).","journal-title":"Cell"},{"key":"994_CR182","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07571","volume":"4","author":"A Arvey","year":"2015","unstructured":"Arvey, A. et al. Genetic and epigenetic variation in the lineage specification of regulatory T cells. eLife 4, e07571 (2015).","journal-title":"eLife"},{"key":"994_CR183","doi-asserted-by":"publisher","first-page":"100117","DOI":"10.1016\/j.xgen.2022.100117","volume":"2","author":"L Bossini-Castillo","year":"2022","unstructured":"Bossini-Castillo, L. et al. Immune disease variants modulate gene expression in regulatory CD4+ T cells. Cell Genom. 2, 100117 (2022).","journal-title":"Cell Genom."},{"key":"994_CR184","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature23875","volume":"549","author":"DR Simeonov","year":"2017","unstructured":"Simeonov, D. R. et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature 549, 111\u2013115 (2017).","journal-title":"Nature"},{"key":"994_CR185","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-020-2296-7","volume":"583","author":"R Nasrallah","year":"2020","unstructured":"Nasrallah, R. et al. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells. Nature 583, 447\u2013452 (2020).","journal-title":"Nature"},{"key":"994_CR186","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.4049\/jimmunol.2001184","volume":"206","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. BATF regulates T regulatory cell functional specification and fitness of triglyceride metabolism in restraining allergic responses. J. Immunol. 206, 2088\u20132100 (2021).","journal-title":"J. Immunol."},{"key":"994_CR187","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.immuni.2017.07.008","volume":"47","author":"N Hayatsu","year":"2017","unstructured":"Hayatsu, N. et al. Analyses of a mutant Foxp3 allele reveal BATF as a critical transcription factor in the differentiation and accumulation of tissue regulatory T cells. Immunity 47, 268\u2013283.e9 (2017).","journal-title":"Immunity"},{"key":"994_CR188","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","volume":"52","author":"M Delacher","year":"2020","unstructured":"Delacher, M. et al. Precursors for nonlymphoid-tissue Treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. Immunity 52, 295\u2013312.e11 (2020).","journal-title":"Immunity"},{"key":"994_CR189","doi-asserted-by":"publisher","first-page":"eabk0957","DOI":"10.1126\/sciimmunol.abk0957","volume":"7","author":"K Itahashi","year":"2022","unstructured":"Itahashi, K. et al. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Sci. Immunol. 7, eabk0957 (2022).","journal-title":"Sci. Immunol."},{"key":"994_CR190","doi-asserted-by":"publisher","first-page":"1026368","DOI":"10.3389\/fimmu.2023.1026368","volume":"14","author":"C Tikka","year":"2023","unstructured":"Tikka, C. et al. BATF sustains homeostasis and functionality of bone marrow Treg cells to preserve homeostatic regulation of hematopoiesis and development of B cells. Front. Immunol. 14, 1026368 (2023).","journal-title":"Front. Immunol."},{"key":"994_CR191","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ni.3085","volume":"16","author":"A Vasanthakumar","year":"2015","unstructured":"Vasanthakumar, A. et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 16, 276\u2013285 (2015).","journal-title":"Nat. Immunol."},{"key":"994_CR192","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41423-020-00547-x","volume":"18","author":"R Sakai","year":"2021","unstructured":"Sakai, R. et al. Kidney GATA3+ regulatory T cells play roles in the convalescence stage after antibody-mediated renal injury. Cell Mol. Immunol. 18, 1249\u20131261 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"994_CR193","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1172\/JCI130426","volume":"130","author":"G Alvisi","year":"2020","unstructured":"Alvisi, G. et al. IRF4 instructs effector Treg differentiation and immune suppression in human cancer. J. Clin. Invest. 130, 3137\u20133150 (2020).","journal-title":"J. Clin. Invest."},{"key":"994_CR194","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/ni.2006","volume":"12","author":"E Cretney","year":"2011","unstructured":"Cretney, E. et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12, 304\u2013311 (2011).","journal-title":"Nat. Immunol."},{"key":"994_CR195","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature12199","volume":"498","author":"R Roychoudhuri","year":"2013","unstructured":"Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. Nature 498, 506\u2013510 (2013).","journal-title":"Nature"},{"key":"994_CR196","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190711","volume":"217","author":"FM Grant","year":"2020","unstructured":"Grant, F. M. et al. BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression. J. Exp. Med. 217, e20190711 (2020).","journal-title":"J. Exp. Med."},{"key":"994_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14112-2","volume":"11","author":"T Sidwell","year":"2020","unstructured":"Sidwell, T. et al. Attenuation of TCR-induced transcription by Bach2 controls regulatory T cell differentiation and homeostasis. Nat. Commun. 11, 252 (2020).","journal-title":"Nat. Commun."},{"key":"994_CR198","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41590-021-00987-1","volume":"22","author":"A Osman","year":"2021","unstructured":"Osman, A. et al. TCF-1 controls Treg cell functions that regulate inflammation, CD8+ T cell cytotoxicity and severity of colon cancer. Nat. Immunol. 22, 1152\u20131162 (2021).","journal-title":"Nat. Immunol."},{"key":"994_CR199","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","volume":"30","author":"JD Powell","year":"2012","unstructured":"Powell, J. D., Pollizzi, K. N., Heikamp, E. B. & Horton, M. R. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30, 39\u201368 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"994_CR200","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri3198","volume":"12","author":"H Chi","year":"2012","unstructured":"Chi, H. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325\u2013338 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"994_CR201","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng, H. et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 499, 485\u2013490 (2013).","journal-title":"Nature"},{"key":"994_CR202","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04392-5","volume":"9","author":"NM Chapman","year":"2018","unstructured":"Chapman, N. M. et al. mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis. Nat. Commun. 9, 2095 (2018).","journal-title":"Nat. Commun."},{"key":"994_CR203","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11581","volume":"491","author":"W Ouyang","year":"2012","unstructured":"Ouyang, W. et al. Novel Foxo1-dependent transcriptional programs control Treg cell function. Nature 491, 554\u2013559 (2012).","journal-title":"Nature"},{"key":"994_CR204","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2010.12.002","volume":"33","author":"YM Kerdiles","year":"2010","unstructured":"Kerdiles, Y. M. et al. Foxo transcription factors control regulatory T cell development and function. Immunity 33, 890\u2013904 (2010).","journal-title":"Immunity"},{"key":"994_CR205","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41590-019-0442-x","volume":"20","author":"LM Charbonnier","year":"2019","unstructured":"Charbonnier, L. M. et al. Functional reprogramming of regulatory T cells in the absence of Foxp3. Nat. Immunol. 20, 1208\u20131219 (2019).","journal-title":"Nat. Immunol."},{"key":"994_CR206","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature16486","volume":"529","author":"CT Luo","year":"2016","unstructured":"Luo, C. T., Liao, W., Dadi, S., Toure, A. & Li, M. O. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature 529, 532\u2013536 (2016).","journal-title":"Nature"},{"key":"994_CR207","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/intimm\/dxac013","volume":"34","author":"J Nagasaki","year":"2022","unstructured":"Nagasaki, J. & Togashi, Y. A variety of \u2018exhausted\u2019 T cells in the tumor microenvironment. Int. Immunol. 34, 563\u2013570 (2022).","journal-title":"Int. Immunol."},{"key":"994_CR208","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1073\/pnas.1608873113","volume":"113","author":"B Zhang","year":"2016","unstructured":"Zhang, B., Chikuma, S., Hori, S., Fagarasan, S. & Honjo, T. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Proc. Natl Acad. Sci. USA 113, 8490\u20138495 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR209","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182232","volume":"218","author":"CL Tan","year":"2021","unstructured":"Tan, C. L. et al. PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance. J. Exp. Med. 218, e20182232 (2021).","journal-title":"J. Exp. Med."},{"key":"994_CR210","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature23665","volume":"548","author":"K Yang","year":"2017","unstructured":"Yang, K. et al. Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling. Nature 548, 602\u2013606 (2017).","journal-title":"Nature"},{"key":"994_CR211","doi-asserted-by":"publisher","first-page":"eabn6173","DOI":"10.1126\/sciimmunol.abn6173","volume":"8","author":"M van Gulijk","year":"2023","unstructured":"van Gulijk, M. et al. PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Sci. Immunol. 8, eabn6173 (2023).","journal-title":"Sci. Immunol."},{"key":"994_CR212","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada, T. et al. PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc. Natl Acad. Sci. USA 116, 9999\u201310008 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"994_CR213","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai, S. et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell 40, 201\u2013218.e9 (2022).","journal-title":"Cancer Cell"},{"key":"994_CR214","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85935","volume":"1","author":"DE Lowther","year":"2016","unstructured":"Lowther, D. E. et al. PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight 1, e85935 (2016).","journal-title":"JCI Insight"},{"key":"994_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21861-5","volume":"8","author":"M Sambucci","year":"2018","unstructured":"Sambucci, M. et al. FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis. Sci. Rep. 8, 3674 (2018).","journal-title":"Sci. Rep."},{"key":"994_CR216","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219086120","volume":"120","author":"C Lamarche","year":"2023","unstructured":"Lamarche, C. et al. Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion. Proc. Natl Acad. Sci. USA 120, e2219086120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-00994-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-00994-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-00994-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T09:05:30Z","timestamp":1719824730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-00994-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":216,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1038\/s41577-024-00994-x","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]},"assertion":[{"value":"15 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.A.H. has received research funding from Bristol-Myers Squibb, Novartis, Sanofi and Genentech, and has been a consultant for Bayer Pharmaceuticals, Repertoire, Bristol-Myers Squibb, Compass Therapeutics, EMD Serono, Genentech, Juno therapeutics, Novartis Pharmaceuticals, Proclara Biosciences, Sage Therapeutics and Sanofi Genzyme.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}